InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,863.60
(
0.09%
)
Dow Jones
39,375.87
(
0.00%
)
Brent Oil
85.86
(
-0.75%
)
Bitcoin
57,191.90
(
2.41%
)
Post# of 2543
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

KEEMAJO

Send PM Follow Ignore
Followers 0
Posts 1624
Boards Moderated 0
Alias Born 06/13/2011

KEEMAJO

Re: Ultimate Warrior post# 1389

Monday, 10/03/2016 10:03:37 AM

Monday, October 03, 2016 10:03:37 AM

Post# of 2543
Biosurface became INTEGUMEN whom EHSK has the Agreement with. Innovenn is a division of Venn Life Sciences and the sale is pending at this point.

The below is from the Venn website a while back. The sale of Innovenn is now imminent.

"The Company has entered into a process to sell its innovation division, Innovenn. This sale will represent the culmination of several months of effort to re-position Innovenn in such a way that will bring better clarity to the performance of the core business, and realise value from our investment in Innovenn."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up